Form 8-K · Current report

Ametek 8-K, filed Aug 26, 2026

Filed
CIK
0001037868
Accession no.
0001037868-26-000191
AI-generated summary

Summary

Yes. AMETEK said it completed its previously announced all-cash acquisition of Indicor Instrumentation, a portfolio of instrumentation businesses from Indicor, LLC, for $5.0 billion. The acquired businesses, which the company said are expected to add about $350 million to 2026 sales and to be modestly accretive to 2026 adjusted earnings, will join AMETEK's Electronic Instruments Group and Electromechanical Group.

Key points

  • The transaction was all-cash and valued at $5.0 billion.
  • Indicor Instrumentation designs and manufactures instrumentation for industrial and scientific applications, with recurring revenue from consumables, services and aftermarket support.
  • Chairman and CEO David A. Zapico said the acquisition fits AMETEK's operating model and creates integration opportunities.
  • AMETEK reported annualized sales of approximately $9.0 billion and said it is a component of the S&P 500.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 8.01Other Events
  • 9.01Financial Statements and Exhibits

From the filing

Item 8.01 Other Events On August 26, 2026, the Company issued a press release announcing the completion of its previously announced acquisition of a portfolio of instrumentation businesses from Indicor, LLC ("Indicor Instrumentation"), comprising leading businesses that design and manufacture mission-critical solutions for demanding industrial and scientific applications. A copy of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Ametek in Readster

Add Ametek to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.